Cite
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
MLA
Quivoron, C., et al. “Sensitivity, Specificity, and Accuracy of Molecular Profiling on Circulating Cell-Free DNA in Refractory or Relapsed Multiple Myeloma Patients, Results of MM-EP1 Study.” Leukemia & Lymphoma, vol. 65, no. 6, June 2024, pp. 789–99. EBSCOhost, https://doi.org/10.1080/10428194.2024.2320258.
APA
Quivoron, C., Michot, J.-M., Danu, A., Lecourt, H., Saada, V., Saleh, K., Vergé, V., Cotteret, S., Bernard, O. A., & Ribrag, V. (2024). Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study. Leukemia & Lymphoma, 65(6), 789–799. https://doi.org/10.1080/10428194.2024.2320258
Chicago
Quivoron, C., J.-M. Michot, A. Danu, H. Lecourt, V. Saada, K. Saleh, V. Vergé, S. Cotteret, O. A. Bernard, and V. Ribrag. 2024. “Sensitivity, Specificity, and Accuracy of Molecular Profiling on Circulating Cell-Free DNA in Refractory or Relapsed Multiple Myeloma Patients, Results of MM-EP1 Study.” Leukemia & Lymphoma 65 (6): 789–99. doi:10.1080/10428194.2024.2320258.